NOTCH1 is a critical oncogenic driver in T-ALL, and activating NOTCH1 mutations are present in around 60% of T-ALL patient tumors (Radtke et al., 2004; Weng et al., 2004). The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.